chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site reaction
Clinical narrative: Information has been received from a nurse concerning four patients who on unspecified dates was vaccinated with a dose of VARIVAX (Merck) (LOT# not reported). On unreported dates, after vaccination, the patients experienced local injection site reactions. No further information was available at time of this report. Follow-up information has been received from a nurse concerning a 4 year old male who in the week or so of 24-JUL-2009 was vaccinated with a dose of VARIVAX (Merck). "During the week or so of 24-JUL-2009", the patient experienced site reactions. He had recovered at the time of this report. Follow up information has been received from a registered nurse concerning a 4 year old male patient with no illness at time of vaccination who on 30-JUL-2009 was vaccinated SQ with the second dose of VARIVAX (Merck) (lot# 664355/0655Y). Secondary suspect vaccination on the same day included the second SQ dose of MMR II (lot# 663798/0357Y). Concomitant vaccinations on the same day included a first dose of DTaP (IM, lot# C3141AA) and a fourth dose of Poliovirus vaccine inactivated (unspecified) (IM lot# B0475). On 31-JUL-2009, at 12:59 PM, the patient experienced local reaction, redness and induration from deltoid to elbow. Medical attention was sought, the patient had an office visit. The patient was treatment with MOTRIN and ice. On an unspecified date, the adverse events resolved without further incident. This is one of several reports from the same source. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Body temperature increased, Injection site reaction, Oedema peripheral, Pain in extremity
Clinical narrative: Information has been received from a nurse concerning four patients who on unspecified dates was vaccinated with a dose of VARIVAX (Merck) (LOT# not reported). On unreported dates, after vaccination, the patients experienced local injection site reactions. No further information was available at the time of this report. Follow-up information has been received from a nurse concerning a 4 year old male who in the week or so of 24-JUL-2009 was vaccinated with a dose of VARIVAX (Merck). "During the week or so of 24-JUL-2009", the patient experienced injection site reactions. He had recovered at the time of this report. Follow-up information has been received from a nurse concerning the patient who on 30-JUL-2009 was vaccinated with his second dose of VARIVAX (Merck) (SC, lot # "0549Y"). Suspect vaccines included the second SQ dose of MMR II (MSD) (lot # 653749/0427F), the fourth IM dose of IPOL (lot # B6475), and fifth IM dose of DAPTACEL (lot #C3141AA). On 31-JUL-2009 in the afternoon, the patient's left upper arm was sore and swollen. His body temperature was 101 F. The patient was treated with BENADRYL (dose and duration not reported), TYLENOL (dose and duration not reported) and ice. It was reported that the patient also experienced edema to the elbow (which elbow was not specified), the patient received the IPOL and DAPTACEL in this arm. The patient visited the doctor for medical attention. At the time of this report, the patient was recovered. This is one of several reports from the same source. Additional information is not expected.
Age: 17.0
Sex: U
Vaccine: VARCEL
Symptoms: No therapeutic response
Clinical narrative: Information has been received from a pharmacy student concerning a 17 year old patient who on unspecified dates has been vaccinated with two doses of VARIVAX (Merck) (LOT numbers not reported) but has still not seroconverted. No further information was available at the time of this report. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: DTAP, MNQ, VARCEL
Symptoms: Pruritus, Pyrexia, Skin lesion
Clinical narrative: Information has been received from a nurse concerning a 13 year old female with no pertinent medical history and no drug allergy who on 27-JUL-2009 was vaccinated subcutaneously with a 0.5mL dose of VARIVAX (Merck) (LOT# not reported). Concomitant vaccinations included MENACTRA and DTAP. On 05-AUG-2009 the patient experienced chickenpox type lesions all over her body after receiving a dose of VARIVAX (Merck). The lesions were itchy and the patient also had fever. There was no lab diagnostics performed. The patient called the nurse and she was recovering. Follow up information has been received from the licensed visiting nurse who stated that the rash was not chicken pox and there was no reaction to VARIVAX (Merck). Additional information has been requested.
Age: 2.2
Sex: F
Vaccine: VARCEL
Symptoms: Polymerase chain reaction, Skin lesion, Varicella post vaccine, Varicella virus test negative
Clinical narrative: Initial and follow up information has been received from a pharmacist concerning her daughter, a 31 month old female with no drug allergies and no pertinent medical history who on an unspecified date was vaccinated with the first "standard dose" of VARIVAX (Merck) (LOT # not reported).  On 25-JUL-2009 the patient experienced varicella rashes, it was a full blown chicken pox and it was 10 days since she started to have them.  The patient still had lesions until now.  On 03-AUG-2009 the patient experienced infection.  The patient sought medical attention as her mother is a pharmacist.  It was noted that the patient did not received the second dose of VARIVAX (Merck).  The patient was being treated with acyclovir.  It was noted by the pharmacist that her son, a 5 year old male who received the first dose of VARIVAX (Merck) on an unspecified date, received the second dose on 22-JUL-2009.  The pharmacist thought that since her son received the second dose of VARIVAX (Merck) that might have triggered her daughter to develop chicken pox.  The patient had not recovered at this time.  The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV was present and if it was present, to identify if it was associated with the wild-type (WT) VZV strain or with the Merck vaccine strain.  The specimen was collected on 06-AUG-2009 from back side of right leg and the type was lesion (scab).  The specimen on 07-AUG-2009 had arrived in laboratory.  The VZV DNA and beta-globin DNA were not amplified.  The PCR analysis of the vesicular specimen revealed it was inadequate.  There was "lots of material" but no beta-globin identified.  This is an amended report.  The two terms of "rash vesicular" has been deleted since the patient was diagnosed with chickenpox.  The second to last sentence of the narrative has been updated.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Information has been received from a nurse practitioner concerning a patient who was vaccinated with the second dose of VARIVAX (Merck) (lot #657449/0597U, route and site of administration not reported).  On unspecified date, the patient developed an immediate reaction at the injection site of redness, warmth, itching and burning.  The patient's outcome was unknown.  Follow up information has been received from the nurse practitioner concerning the patient with no pre-existing allergies or medical conditions who on an unspecified date developed immediate injection site redness, swelling, itching and burning after vaccination with VARIVAX (Merck).  There was no illness at time of vaccination.  The patient did not seek medical attention.  At the time of this report, the patient's outcome was unknown.  This is one of several cases from the same source.  Additional information is not expected.
Age: 11.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 11 year old patient who on 1-FEB-1998 was vaccinated with a dose of VARIVAX (Merck). On approximately 01-NOV-2006 the patient experienced 20 varicella lesions. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 8 year old patient who on 23-SEP-1998 was vaccinated with a dose of VARIVAX (Merck) (lot#631072/0449J). On approximately 06-FEB-2007, the patient developed varicella. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 0.73
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 10 year old patient who on 27-MAY-1997 was vaccinated with a dose of VARIVAX (Merck). On approximately 06-FEB-2007, the patient developed shingles. At the time of the report, the patients' outcome was unknown. This is one of several reports from the same source. No further information is available.
Age: 1.01
Sex: U
Vaccine: VARCEL
Symptoms: Blister
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 8 year old patient who on 01-MAR-2000 was vaccinated with a dose of VARIVAX (Merck). On approximately 08-MAR-2007, the patient experienced 25 vesicles. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 4 year old patient who on 09-MAY-2003 was vaccinated with a dose of VARIVAX (Merck).  On approximately 19-MAR-2007, the patient developed few lesions.  At the time of the report, the patients' outcome was unknown.  No further information is available.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 5 year old patient who on 05-JAN-2004 and on 12-FEB-2007 was vaccinated with the first and second (lot# 656079/1306F) doses of VARIVAX (Merck). On approximately 27-MAR-2007, the patient developed small lesions scattered. At the time of the report, the patient's outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 1.06
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning an 5 year old patient who on 15-MAY-2002 was vaccinated with a dose of VARIVAX (Merck). On approximately 26-MAR-2007, the patient experienced few pox lesions. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 6.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 6 year old patient who on an unspecified date was vaccinated with a dose of VARIVAX (Merck). On approximately 28-MAR-2007, the patient developed approximately 10 lesions. At the time of report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 1.05
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 30 month old patient who on 11-OCT-2005 was vaccinated with a dose of VARIVAX (Merck). On approximately 20-APR-2007, the patient experienced varicella. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 1.01
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 11 month old patient who on 10-AUG-2007 was vaccinated with a dose of VARIVAX (Merck) (lot# 626960/0847H). On approximately 27-AUG-2007, the patient experienced varicella. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 11.0
Sex: F
Vaccine: MMR
Symptoms: Mumps, Parotid gland enlargement
Clinical narrative: Information has been received from a physician concerning a cluster of among six girls in one classroom who were approximately 11 years old who on unspecified date had received 2 doses of MMR II vaccine (doses, duration and lot numbers were not reported). The physician reported that he had done some laboratory work to confirm the diagnosis of mumps in a few children. He indicated that he did not find any children who were immunoglobulin M (IgM) positive for mumps, but most were immunoglobulin G (IgG) positive. The physician said that most children had parotid gland swelling. At the time of the report, the patient's statuses were unknown. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. This is one of several reports from the same source. Additional information has been requested
Sex: U
Vaccine: MMR
Symptoms: Mumps antibody test positive, Parotid gland enlargement
Clinical narrative: Information has been received from a physician concerning a child who on unspecified dates had received 2 doses of MMR II vaccine (doses, duration and lot numbers were not reported). The physician reported that he had done some laboratory work to confirm the diagnosis of mumps. He indicated that he did not find the child to be immunoglobulin M (IgM) positive for mumps, but was immunoglobulin G (IgG) positive. The physician said the child had a four fold rise in mumps antibody titer. It was noted that the child had parotid gland swelling. At the time of the report, the patient's status was unknown. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Inappropriate schedule of drug administration, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her friend's child who was vaccinated with a second dose of MMR II within days of the first dose. Subsequently the patient experienced high fevers and the patient was "never the same". No further information is available.
Age: 1.02
Sex: M
Vaccine: MMR
Symptoms: Rash generalised
Clinical narrative: Information has been received from a physician concerning a 12 month old male patient with unspecified pertinent medical history, drug reactions or allergies, who "three years ago", on 09-NOV-2006 was vaccinated with a dose of MMR II vaccine (route unknown, lot # 652481/0094F, HSA). Concomitant medication unspecified. The patient developed rash all over his body 15-20 minutes after receiving the dose of MMR II vaccine, he went to the emergency room for medical attention but he was not admitted. On an unspecified date the patient recovered within 24 hours with the use of BENADRYL. Additional information has been requested.
Age: 0.93
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash generalised
Clinical narrative: Information has been received from a registered nurse concerning a male patient who in 1997 was vaccinated with the first dose of MMR II. Subsequently the patient experienced a widespread rash and low-grade fever after the vaccination. Unspecified medical attention had been sought. The patient had recovered on an unspecified day. No further information is available.
Age: 8.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Incorrect dose administered, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a doctor of pharmacy concerning an 8 year old male patient who in 2003 was vaccinated subcutaneously with the first dose 0.5 ml dose of MMR II and the second dose in 2006. Secondary suspect vaccine included varicella received on 04-AUG-2009. The pharmacist reported that the patient who inadvertently received a third dose of MMR II, developed redness, swelling and warmth on the left arm at the injection site on 05-AUG-2009. The affected area was about 2 inches in diameter. At the time of reporting the patient had not recovered. The patient sought unspecified medical attention. Additional information has been requested.
Age: 7.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 10 year old patient who on 10-OCT-2003 was vaccinated with a dose of VARIVAX (Merck).  On approximately 16-NOV-2007 the patient developed more than 100 lesions.  At the time of the report, the patients' outcome was unknown.  This is one of several reports received from the same source.  No further information is available.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 8 year old patient who on 06-NOV-2000 was vaccinated with a dose of VARIVAX (Merck). On approximately 15-NOV-2007, the patient experienced about 25 to 30 lesions. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 0.8
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 10 month old patient who on an unspecified date was vaccinated with a dose of VARIVAX (Merck). On approximately 04-DEC-2007, the patient developed 75 to 100 lesions. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 1.05
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 4 year old patient who on 31-JAN-2005 was vaccinated with a dose of VARIVAX (Merck) (lot# 649848/0769P). On approximately 22-FEB-2008, the patient experienced 50 to 100 lesions. At the time of the report, the patients' outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 1.03
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 10 year old patient who on 11-SEP-1998 was vaccinated with a dose of VARIVAX (Merck). On approximately 10-APR-2008, the patient experienced 1 to 2 lesions. At the time of the report, the patient's outcome was unknown. This is one of several reports received from the same source. No further information is available.
Age: 45.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a pharmacist concerning a 45 year old female patient with no pertinent medical history who as a child was vaccinated with a dose of MMR II. In July 2008 a rubeola titer was performed and the result was negative. Then the patient was vaccinated with a second and third dose of MMR II in August 2008 and in September 2008 respectively. Then in October 2009 a rubeola titer was performed and the result still negative. At the time of the report the patient had not recovered. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: MMR
Symptoms: Body temperature increased, Lymphadenopathy, Measles, Measles antibody negative, Pyrexia
Clinical narrative: Information has been received from a consumer concerning her a 6 year old son with allergic to penicillin and 'sephacillin's" and no medical history who on 20-JUL-2009 was vaccinated with single dose of MMR II. There was no concomitant medication. On 25-Jul-2009 the patient developed a rash on his legs, arms and a slight rash on his trunk, had swollen lymph nodes that last about 24 to 48 hours and had a 103 degree fever for about three days. The patient saw his physician who did a blood test and a flu test and was told that the rash was a measles rash. The patient has been to the physician's office about four times now and was running a 100 degree to 102 degree fever on and off now for about two weeks. The patient had not recovered. Follow-up information has been received from the consumer who reported that tests had confirmed that her son did not have immunity to mumps. She also stated that he did have immunity to Rubella and that they are waiting on the test results regarding Measles. No further information is available.
Age: 6.0
Sex: M
Vaccine: MMR
Symptoms: Rash generalised
Clinical narrative: Information has been received from a consumer concerning her a 6 year old son with allergic to penicillin and 'sephacillin's" and no medical history who on 20-JUL-2009 was vaccinated with single dose of MMR II. There was no concomitant medication. On 25-Jul-2009 the patient developed a rash on his legs, arms and a slight rash on his trunk, had swollen lymph nodes that last about 24 to 48 hours and had a 103 degree fever for about three days. The patient saw his physician who did a blood test and a flu test and was told that the rash was a measles rash. The patient has been to the physician's office about four times now and was running a 100 degree to 102 degree fever on and off now for about two weeks. The patient had not recovered. Follow-up information has been received from the consumer who reported that tests had confirmed that her son did not have immunity to mumps. She also stated that he did have immunity to Rubella and that they are waiting on the test results regarding Measles. No further information is available.
Age: 1.1
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 38 month old patient who on 15-MAR-2006 was vaccinated with a dose of VARIVAX (Merck) (lot# 652456/1019R, route and site of administration not reported). On approximately 12-APR-2008 the patient developed chickenpox, lesions all over body. At the time of reporting, the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: Information has been received from a consumer concerning her daughter who on unspecified dates was vaccinated with all three doses of MMR II. Recently when the patient had titer shot the results came in that she had low immunity to the rubella vaccine. At the time of the report, the patient's outcome was unknown. No further information is available.
Sex: U
Vaccine: MMR, VARCEL
Symptoms: Hypersensitivity, Rash
Clinical narrative: Information has been received from a pharmacist concerning a patient who is a child who on an unspecified date was vaccinated with a dose of MMR II and a dose of VARIVAX (MSD). Subsequently the patient had "an allergic reaction which involved a rash". The pharmacist did not know if this was dose 1 or 2 of MMR II and VARIVAX (MSD). Additional information has been requested.
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Body temperature increased, Pyrexia
Clinical narrative: Information ahs been received from a consumer concerning her son who on an unspecified date was vaccinated with the first 0.5 ml dose of MMR II and "a varicella vaccine (name/manufacturer unknown)" concomitantly. Subsequently the patient experienced a fever of 105 degrees. It was unknown if the patient sought medical attention. At the time of reporting, the patient's outcome was unknown. This is one of several reports received from the same source. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Abdominal pain upper, Arthralgia, Back pain, Chest pain, Chills
Clinical narrative: Information has been received from a consumer concerning her daughter with no known drug allergies who was vaccinated with a dose of MMR II (dose, route and lot# not reported) as a young child. The patient had a severe reaction with parotitis and was hospitalized for 2 weeks. The patient's outcome was unknown. The patient subsequently experienced throat closing, could not breathe, chest pain, chills, burning of throat, chest "like severe reflex", pain in left elbow joint and left side of neck, stabbing pain in leg, visual issues "like letters moving around", panic attack, feeling of "everything got small around her", stabbing knife pain in back, stabbing knife pain in ribs and side, cramping of stomach and severe back pain while on therapy with RECOMBIVAX HB (WAES# 0908USA03760). Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Dyspnoea, Feeling abnormal, Flank pain, Gastrooesophageal reflux disease, Musculoskeletal chest pain
Clinical narrative: Information has been received from a consumer concerning her daughter with no known drug allergies who was vaccinated with a dose of MMR II (dose, route and lot# not reported) as a young child. The patient had a severe reaction with parotitis and was hospitalized for 2 weeks. The patient's outcome was unknown. The patient subsequently experienced throat closing, could not breathe, chest pain, chills, burning of throat, chest "like severe reflex", pain in left elbow joint and left side of neck, stabbing pain in leg, visual issues "like letters moving around", panic attack, feeling of "everything got small around her", stabbing knife pain in back, stabbing knife pain in ribs and side, cramping of stomach and severe back pain while on therapy with RECOMBIVAX HB (WAES# 0908USA03760). Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Neck pain, Pain in extremity, Panic attack, Parotitis, Throat irritation
Clinical narrative: Information has been received from a consumer concerning her daughter with no known drug allergies who was vaccinated with a dose of MMR II (dose, route and lot# not reported) as a young child. The patient had a severe reaction with parotitis and was hospitalized for 2 weeks. The patient's outcome was unknown. The patient subsequently experienced throat closing, could not breathe, chest pain, chills, burning of throat, chest "like severe reflex", pain in left elbow joint and left side of neck, stabbing pain in leg, visual issues "like letters moving around", panic attack, feeling of "everything got small around her", stabbing knife pain in back, stabbing knife pain in ribs and side, cramping of stomach and severe back pain while on therapy with RECOMBIVAX HB (WAES# 0908USA03760). Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Throat tightness, Visual impairment
Clinical narrative: Information has been received from a consumer concerning her daughter with no known drug allergies who was vaccinated with a dose of MMR II (dose, route and lot# not reported) as a young child. The patient had a severe reaction with parotitis and was hospitalized for 2 weeks. The patient's outcome was unknown. The patient subsequently experienced throat closing, could not breathe, chest pain, chills, burning of throat, chest "like severe reflex", pain in left elbow joint and left side of neck, stabbing pain in leg, visual issues "like letters moving around", panic attack, feeling of "everything got small around her", stabbing knife pain in back, stabbing knife pain in ribs and side, cramping of stomach and severe back pain while on therapy with RECOMBIVAX HB (WAES# 0908USA03760). Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Convulsion
Clinical narrative: Information has been received from a consumer concerning her currently "42 years old" husband who was vaccinated with a single dose of MMR II injection when he was an infant. The consumer reported that her husband had a history of vaccine induced seizures. When the patient was due for his routine vaccines (as a child) and one of the vaccines that caused the seizures was MMR II. The other vaccines names and manufacturers were unspecified. The patient had recovered. Up on internal review, seizure was considered to be an other important medical event. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a consumer concerning her daughter who on an unspecified date was vaccinated with a dose of MMR II. Subsequently the patient had an allergic reaction and was hospitalized (name, address and phone number unspecified). At the time of the report, the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.
Age: 1.17
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 7 year old patient who on 29-MAY-2002 was vaccinated with a dose of VARIVAX (Merck) (lot#, route and site of administration not reported). On approximately 14-APR-2008 the patient developed 5 small chickenpox. At the time of the reporting, the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Blood immunoglobulin G, Mumps, Parotid gland enlargement
Clinical narrative: Information has been received from a former clinical investigator concerning a cluster of approximately 114-115 patients from a original group of approximately 128 patients, of unspecified age and sex who on an unspecified date were vaccinated with a dose of MMR II (route and lot # unknown) and on an unspecified date they experienced mumps. The physician reported that he has done some laboratory work to confirm the diagnosis of mumps in a few children and he did not find any children who were IgM positive for mumps, but most were IgG positive. The physician stated that most children had a parotid gland swelling. It was unknown is the patients sought medical attention. At the time of the report the patient's outcome was unknown. This is one of several reports from the same source. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Hepatitis B antibody positive, Measles antibody negative, Mumps antibody test negative, Rubella antibody positive, Unevaluable event
Clinical narrative: Information has been received from a registered nurse concerning a approximately 20 year old patient who was vaccinated with the first and second dose of MMR II at 13 months and 4 years respectively.  The patient was recently given another dose of MMR II (date unspecified).  The patient still has negative titers (nurse did not know if the patient had negative titers to MMR).  No adverse reactions reported and no other information was reported from the reporter.  Follow-up information was received from the registered nurse and medical records concerning the 19 year old female patient (previously reported as 20) who on 28-DEC-1990 was vaccinated subcutaneously with the first dose of MMR into her right arm.  On 11-AUG-1994 was vaccinated with the second dose of MMR (lot number not provided).  Concomitant vaccination on 11-AUG-1994 included the fifth dose of DTAP and the fourth dose of POLIO virus vaccine live oral.  On 16-JUL-2009 laboratory evaluation revealed the patient's rubeola IgG was negative.  On 20-JUL-2009, the patient was vaccinated subcutaneously with a third dose of MMR (lot # 663929/0511Y) into her left arm.  There was no known illness at the time of vaccination.  On 11-AUG-2009 laboratory evaluation revealed the patient's rubeola IgG was equivocal.  At the time of the report, the patient recovered.  Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Varicella virus test positive
Clinical narrative: Information has been received from a registered nurse concerning a approximately 20 year old patient who was vaccinated with the first and second dose of MMR II at 13 months and 4 years respectively.  The patient was recently given another dose of MMR II (date unspecified).  The patient still has negative titers (nurse did not know if the patient had negative titers to MMR).  No adverse reactions reported and no other information was reported from the reporter.  Follow-up information was received from the registered nurse and medical records concerning the 19 year old female patient (previously reported as 20) who on 28-DEC-1990 was vaccinated subcutaneously with the first dose of MMR into her right arm.  On 11-AUG-1994 was vaccinated with the second dose of MMR (lot number not provided).  Concomitant vaccination on 11-AUG-1994 included the fifth dose of DTAP and the fourth dose of POLIO virus vaccine live oral.  On 16-JUL-2009 laboratory evaluation revealed the patient's rubeola IgG was negative.  On 20-JUL-2009, the patient was vaccinated subcutaneously with a third dose of MMR (lot # 663929/0511Y) into her left arm.  There was no known illness at the time of vaccination.  On 11-AUG-2009 laboratory evaluation revealed the patient's rubeola IgG was equivocal.  At the time of the report, the patient recovered.  Additional information is not expected.
Age: 8.0
Sex: F
Vaccine: MMR
Symptoms: Dermatitis, Eczema, Erythema, Injection site induration, Injection site mass
Clinical narrative: Information has been received from a registered nurse concerning a 8 year old female with no known drug allergies and no pertinent medical history, who on 10-AUG-2009 was vaccinated intramuscularly in the left arm with MMR II.  There was no concomitant medication.  The registered nurse reported that on 10-AUG-2009, the patient developed a 2 cm nonerythematous "mass" with induration at the injection site after administration of MMR II.  The site of injection was also tender.  The registered nurse also reported that the patient at 6 weeks of age had a reaction to an immunization.  The nurse did not know which vaccine or what type of reaction.  At the time of the report, the patient had not recovered.  The patient was seen for an office visit.  Follow up information has been received from a physician via medical records concerning the patient who was vaccinated with MMR II in the right deltoid (previously reported as left arm).  On 12-AUG-2009, brief normal exam in skin showed induration and mass present in the left arm of 2 cm, no erythema.  On 24-AUG-2009, the patient's mother consulted the physician because on 23-AUG-2009 the patient had splinter in foot from wood chip and wanted to check site of MMR II given two weeks ago.  Dermatology examination showed in the right arm a small patch overlying deltoid mild papules, mild erythema anterior shoulder at junction of axilla.  The assessment was dermatitis, irritation of arm from seat belt and mild eczemoid reaction deltoid.  The treatment for the dermatitis was CORTAID.  Additional information has been requested.
Age: 8.0
Sex: F
Vaccine: MMR
Symptoms: Injection site pain, Rash papular, Skin irritation
Clinical narrative: Information has been received from a registered nurse concerning a 8 year old female with no known drug allergies and no pertinent medical history, who on 10-AUG-2009 was vaccinated intramuscularly in the left arm with MMR II.  There was no concomitant medication.  The registered nurse reported that on 10-AUG-2009, the patient developed a 2 cm nonerythematous "mass" with induration at the injection site after administration of MMR II.  The site of injection was also tender.  The registered nurse also reported that the patient at 6 weeks of age had a reaction to an immunization.  The nurse did not know which vaccine or what type of reaction.  At the time of the report, the patient had not recovered.  The patient was seen for an office visit.  Follow up information has been received from a physician via medical records concerning the patient who was vaccinated with MMR II in the right deltoid (previously reported as left arm).  On 12-AUG-2009, brief normal exam in skin showed induration and mass present in the left arm of 2 cm, no erythema.  On 24-AUG-2009, the patient's mother consulted the physician because on 23-AUG-2009 the patient had splinter in foot from wood chip and wanted to check site of MMR II given two weeks ago.  Dermatology examination showed in the right arm a small patch overlying deltoid mild papules, mild erythema anterior shoulder at junction of axilla.  The assessment was dermatitis, irritation of arm from seat belt and mild eczemoid reaction deltoid.  The treatment for the dermatitis was CORTAID.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: HEP, MMR
Symptoms: Dehydration, Lethargy, Pyrexia, Urticaria, Vomiting
Clinical narrative: Information has been received from a consumer concerning her 4 year old son with no pertinent medical history reported and no known drug allergies, who on 18-NOV-2005 was vaccinated with first 0.5mL dose of MMR II (route and lot number not reported) and secondary suspect RECOMBIVAX (manufacturer unknown) (dose, route and lot number not reported). Concomitant therapy included polio vaccine (manufacturer unknown). The patient's mother stated that on the same date, 18-NOV-2005, the patient experienced hives, fever, lethargy, vomiting and dehydration. The patient recovered from the events within 36-48 hours after symptoms staring. No lab studies were performed. It was noted that the patient had a similar experienced after receiving DTaP(manufacturer unknown) on 4-FEB-2005. The patient sought unspecified medical attention. Additional information has been requested.
Age: 1.03
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Erythema, Wrong technique in drug usage process
Clinical narrative: Information has been received from a nurse practitioner concerning a 12 month old female who on 02-SEP-2009 was vaccinated SQ with 0.3 ml first dose of MMR II (lot number: 663857/0355Y). Suspect therapy included VARIVAX (Merck) SQ on 02-SEP-2009 (lot number: 664933/0866Y). The nurse practitioner reported that while giving a child the first dose of MMR II the syringe became faulty and only 0.3 ml was administered. This was an office syringe. The patient also received VARIVAX (Merck) in the same thigh. An area on the thigh was slightly red after administration but was unknown if it was from of MMR II or VARIVAX (Merck). The patient sought unspecified medical attention. At the time of the report the outcome of the patient was recovering. Follow-up information has been received from the nurse practitioner concerning the infant with no known drug allergies and no past medical history who was vaccinated on 02-SEP-2009 with a SQ first dose of MMR II (663857/0355Y) at 10:00 AM in the left thigh. There was no illness at the time of vaccination. The nurse practitioner reported that they were unable to administer more than 0.3 ml of MMR II due to a faulty syringe. They did not give the balance of MMR II with the new syringe as the patient's thigh appeared red where the partial dose had been given. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: No therapeutic response
Clinical narrative: Information has been received from a physician's assistant concerning an adult male who on an unspecified date (at young age) was vaccinated with a dose of MMR II (dose, route and lot number not reported). It was reported that the patient was tested no immunity to rubella and measles, so the physician gave the patient another dose of the vaccine recently. The patient sought medical attention by contacting the physician's assistant. This is one of several reports from the same source. The health care professional contacted during telephone follow up could not supply the following information: patient name, date of birth, dates of vaccination, dose number, lot number or recovery status. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Abdominal X-ray, Faeces discoloured, Occult blood negative, Pyrexia, Stool analysis normal
Clinical narrative: Information has been received from a consumer concerning her 24 month old son with no medical history or allergies who on 03-AUG-2009 was vaccinated, 0.5 ml, with the first dose of MMR II injection (lot # not reported). The mother also mentioned that her son was administered with single dose of rubella virus vaccine live (MSD). There was no concomitant medication. On 03-AUG-2009, the next bowel movement the patient did was in green grass color. There were no laboratory studies performed. The patient sought unspecified medical attention. At the time of reporting, the patient had not recovered. Follow-up information has been received from a physician concerning the patient with no medical history or allergies, and no illness at time of vaccination who on 03-AUG-2009 was vaccinated subcutaneously with a dose of MMR II (lot # 663877/0356Y). The physician reported the patient experienced green stool for 16 days with no diarrhea, no vomiting, no blood in stool. The patient also experienced fever of 103 on 13-AUG-2009 for 1 day. Stool guaiac test, abdominal x-ray test and stool examination were performed and the results all were negative. There were no adverse events following prior vaccination. The patient had recovered on 19-AUG-2009. Additional information is not expected.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: X-ray normal
Clinical narrative: Information has been received from a consumer concerning her 24 month old son with no medical history or allergies who on 03-AUG-2009 was vaccinated, 0.5 ml, with the first dose of MMR II injection (lot # not reported). The mother also mentioned that her son was administered with single dose of rubella virus vaccine live (MSD). There was no concomitant medication. On 03-AUG-2009, the next bowel movement the patient did was in green grass color. There were no laboratory studies performed. The patient sought unspecified medical attention. At the time of reporting, the patient had not recovered. Follow-up information has been received from a physician concerning the patient with no medical history or allergies, and no illness at time of vaccination who on 03-AUG-2009 was vaccinated subcutaneously with a dose of MMR II (lot # 663877/0356Y). The physician reported the patient experienced green stool for 16 days with no diarrhea, no vomiting, no blood in stool. The patient also experienced fever of 103 on 13-AUG-2009 for 1 day. Stool guaiac test, abdominal x-ray test and stool examination were performed and the results all were negative. There were no adverse events following prior vaccination. The patient had recovered on 19-AUG-2009. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a physician concerning a patient who on 03-SEP-2009 was vaccinated with a dose of MMR II (lot # 664658/0679Y). On 03-SEP-2009 the patient experienced unspecified allergic reaction. At the time of report, the patient's outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Blood immunoglobulin G normal, No therapeutic response, Rubella antibody negative
Clinical narrative: Information has been received from a pharmacist student concerning an "school aged" patient who was vaccinated with two doses of MMR II and still had negative titers to MMR II.  The patient was also given one dose of MERUVAX II a few months ago, but still had negative titers to rubella.  Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Injection site pain, Pain
Clinical narrative: Information has been received from a pharmacist concerning an adult male patient who on approximately 31-AUG-2009 was vaccinated with a dose of MMR II. Subsequently, in 2009, the patient experienced worsening pain at the injection site. The pharmacist reported that upon exam, the injection site showed no obvious reason for the pain; no redness, warmth or swelling. The patient sought unspecified medical attention. At the time of the report, the patient's worsening pain at the injection site had persisted. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Injection site erythema, Pyrexia
Clinical narrative: Information has been received from a licensed practical nurse concerning a 25 month old male child with "delayed immunization altered schedule" and no allergies who on 10-AUG-2009 was vaccinated subcutaneously with 0.5 ml of MMR II (lot # 664607/0609Y) in his right thigh.  There was no concomitant medication.  On 18-AUG-2009 the child was seen in the office and he had fever 37.22 on Temporal Thermometer, and red welt on right thigh.  No treatment.  The nurse stated no follow up visit with the child needed.  There were no laboratory studies performed.  At the time of report, the child had not recovered.  Follow up information was received from a Licensed Practical Nurse (L.P.N.) concerning the 25 month old (also reported as 27 month old) male child with no medical history or concurrent condition who on 10-AUG-2009 at 13:39 PM was vaccinated subcutaneously in the right thigh with the first dose of MMR II (lot # 664607/0609Y).  There was no concomitant medication.  There was no illness at the time of vaccination and adverse event following prior vaccination.  On 10-AUG-2009 the patient developed redness on right thigh and lasted for 8 days.  The patient also experienced fever for 2 days.  The patient recovered on unspecified date.  No relevant diagnostic tests or laboratory data was collected.  No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Laboratory test normal, Viral titre
Clinical narrative: Information has been received from a pre-school teacher concerning her male student who on 03-AUG-2005 was vaccinated with a first dose of MMR II 0.5 mL.  It was reported that recently the patient had a titer test performed and results showed that the patient had less immunity to mumps virus.  The patient sought unspecified medical attention.  Follow up information has been received from a pre-school teacher who reported that she did not have any additional information regarding this particular patient.  Additional information is not expected.
Age: 1.3
Sex: M
Vaccine: MMR
Symptoms: Erythema, Rash, Rubella
Clinical narrative: Information has been received from a mother concerning her 15 month old son with no drug allergy and no pertinent medical history who "when 15 months old" was vaccinated subcutaneously with a 0.5mL dose of MMR II (LOT# not reported).  There was no concomitant medication.  The mother reported that a week after the vaccination, her son experienced redness and rash all over his body that looked like rubella.  She brought him to a nurse who verified that the rash was rubella.  Patient had recovered about a week after the adverse events started.  Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: MMR
Symptoms: Abdominal pain, Chest pain, Decreased appetite, Dyspnoea, Malaise
Clinical narrative: Information has been received from a physician assistant concerning a 23 year old female patient with hypothyroidism who on 23-SEP-2009 was vaccinated with a dose of MMR II, 0.5 ml SC in upper right arm, (Lot # 663524/1727X).  Concomitant therapy included levothyroxine Na.  On 23-SEP-2009 night after receiving the vaccine, the patient's arm was tingling at the injection site and she was experiencing burning across the chest and shortness of breath.  Patient was seen for follow up on 24-SEP-2009 and she stated that she was experiencing decreased appetite, abdominal cramping and shortness of breath.  Injection site tingling was better but client was "still feeling crummy".  Physician assistant stated patient's peak flow measures were within normal limits.  At the time of the report, the patient's AE did not improve.  Additional information has been requested.